Partner, Executive Search
Ken Dropiewski serves as a Partner at McDermott + Bull and is part of the firm’s national MedTech and Life Sciences Group. While he serves the entire Medical Device and Biotechnology industry, Ken is particularly well known for his work within the cardiac, vascular, interventional, and oncology segments.
Ken has been in the Medtech industry for over 25 years. Prior to Ken’s career in executive search, he held various commercial roles within Johnson & Johnson and Boston Scientific, in which he won several acclaimed awards including Ring Club, Grand Awards, and President’s Club. He was the founder and President of Prime-Core Executive Search, a boutique search firm that was formed in 2003 to serve the Medical Device and Biotech industries. During his tenure at Prime-Core, Ken quickly earned the respect of some of the most notable companies in the industry, performing search work for companies like Medtronic and Boston Scientific, as well as some of the most innovative high growth small and mid-cap companies within the space. In 2018, Ken moved Prime-Core’s practice over to McDermott + Bull to better serve his clients and increase his reach. His particular focus is small to mid-cap growth companies, both private and public.
Ken holds a Bachelor of Science in finance from Central Michigan University and an MBA from the University of Colorado in Denver, with a focus on entrepreneurial studies and leadership development.
MedTech + Life Sciences Videos
McDermott + Bull has successfully placed Tammy Hicklin-Estabrook as Vice President of Sales at Nuance Medical. Tammy will be responsible for driving commercial growth and success by establishing multi-faceted sales strategies and leading a high-performing hybrid sales...
McDermott + Bull has successfully placed Tony Titus as Vice President of Global Sales at Clarius Mobile Health. Tony will lead the company’s global, multi-channel commercial growth strategy, with a focus on driving revenue growth of their software-as-a-service (SaaS)...
McDermott + Bull has successfully placed Wendy Werblin as Vice President of Product at Clarius Mobile Health. Wendy will play an important role in driving the organization’s innovation roadmap and product portfolio while developing a high-performing product team....
McDermott + Bull Partner Ken Dropiewski interviews Gilde Healthcare General Partner Geoff Pardo in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Geoff discuss what venture in MedTech will look like in 2023, what Gilde Healthcare looks for in new investment opportunities, and more.
McDermott + Bull Partner Ken Dropiewski interviews Endeavour Venture Partner Rob Barmann in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Rob discuss a range of topics from typical investment sizes to non-traditional MedTech services.
McDermott + Bull Partner Ken Dropiewski interviews CRG Director Sabir Rassiwalla in his series, Investor Insights in Life Sciences + MedTech. In the conversations below, Ken and Sabir discuss MedTech’s continuously changing landscape, what makes CRG different from other healthcare investors, and what to expect to see from the firm in the future.
This week on Investor Insights, host Ken Dropiewski interviews James Eadie, Managing Director of Santé Ventures. They discuss a number of topics including James’s journey into Santé Ventures, Santé’s portfolio, and the working relationship between Santé and early-stage companies.
This week on Investor Insights, host Ken Dropiewski interviews Justin Klein, MD, JD and Kirk Nielsen, both Co-Founders and Managing Partners of Vensana Capital. They discuss a number of topics including the future of MedTech, the changes within the industry over the last ten years, and the history of their company.
This week, host Ken Dropiewski interviews Maria Berkman, Director, Head of MedTech at Broadview Ventures, Inc. They discuss a number of topics including investment targets, the future of MedTech, and the interview process of early-stage investors.
This week, host Ken Dropiewski interviews Paul LaViolette, Managing Partner and Chief Operating Officer of SV Health Investors. They discuss a range of topics, from the timing of investments to important ideas facing the industry.
In this episode of Investor Insights, McDermott + Bull Partner Ken Dropiewski sits down with Managing Director Joe Biller of 3×5 Partners to discuss portfolio companies, investment opportunities, and new technologies in the MedTech + Life Sciences space.
What matters to you, matters to us.
WE’RE PRO YOU.